Ivan A. Chabin

Dr. Ivan A. Chabin

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2026 in Pediatric Hematology/Oncology and Immunopathology
Verified
Journal Article
Open access
AIAnastasia A. Ignatova
Anastasia A. Ignatova
EYE. V. Yushkova
E. V. Yushkova
ICIvan A. Chabin
Ivan A. Chabin
PKP. V. Kralichkin
P. V. Kralichkin
EPE. A. Ponomarenko
E. A. Ponomarenko
MPMikhail A. Panteleev
Mikhail A. Panteleev
Introduction. Essential thrombocythemia (ET) is an orphan myeloproliferative disease with excessive platelet production associated with an increased risk of thrombosis and bleeding. Currently, there is a limited number of studies on the state of platelet hemostasis in children with ET. Aim of this single-center prospective study was to characterize the morphological and functional properties of platelets in pediatric patients with ET. Materials and methods. The study included 30 patients (10 boys and 20 girls) aged 3–17 years with an established diagnosis of ET. The control group consisted of 45 healthy volunteers (22 boys and 23 girls) aged 4–18 years. Flow cytometry with strong and weak activation, aggregometry, and immunofluorescence microscopy of blood smears were used to analyze platelet function. Results. It was shown that platelets of patients with ET are characterized by a reduced size, while the number of platelet alpha and dense granules did not differ from the control group. Platelets of patients with ET showed moderate hyporeactivity in response to strong stimulation (by activation of glycoprotein IIbIIIa and secretion of dense granules). Platelet aggregation with collagen and adenosine diphosphate was also reduced in patients with ET, but these data did not correlate with the degree of platelet activation in flow cytometry. Conclusion. Thus, characteristic morphological and functional changes in platelets were revealed in children with ET compared with the control group.

13 December 2024 in Pediatric Hematology/Oncology and Immunopathology
Verified
Journal Article
Open access
PDF file
EAE. O. Artemenko
E. O. Artemenko
ICIvan A. Chabin
Ivan A. Chabin
MPMikhail A. Panteleev
Mikhail A. Panteleev
The state of platelets may depend on the time since blood draw, primarily because of the presence of short-lived inhibitors of platelet activation in circulation. In this work, we analyzed the phosphorylation of vasodilator-stimulated phosphoprotein (VASP), which correlates with platelet inhibition, over time using flow cytometry. The study was approved by the Independent Ethics Committee and the Scientific Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation. We investigated VASP phosphorylation in platelets in whole blood immediately after the blood was collected and 60 minutes later. As a positive control, we used platelet function inhibition by prostaglandin E1. As a result, it was found that the level of VASP phosphorylation in platelets in whole blood did not differ significantly in samples taken immediately after the blood draw and 60 minutes later, however it was markedly increased with platelet inhibition by prostaglandin E1. Our results suggest that the state of platelets does not change significantly within 60 minutes after the blood draw.

30 June 2025 in Pediatric Hematology/Oncology and Immunopathology
Verified
Journal Article
Open access
PDF file
ICIvan A. Chabin
Ivan A. Chabin
NPNadezhda Podoplelova
Nadezhda Podoplelova
EAElena O. Artemenko
Elena O. Artemenko
NSNikolay N. Starostin
Nikolay N. Starostin
PTPavel Trakhtman
Pavel Trakhtman
MPMikhail A. Panteleev
Mikhail A. Panteleev
A wide use of blood products inevitably leads to an increase in the number of complications associated with it. These complications include thromboembolic events that are considered to be rare and difficult-to-manage. Currently, the mechanisms and possible laboratory predictors of such complications are unclear. This paper presents our experience of using flow cytometry to assess the parameters of phosphatidylserine expression (detected by Annexin V binding) and describes impairments in the deformability of red blood cells (detected using forward and side scatter data) which determine the procoagulant properties of cells. According to our findings, the use of Annexin V for the assessment of gradual cell death in the samples of red blood cell (RBC) suspension is controversial. At the same time, our results show a higher sensitivity of the assessment of the accumulation of RBCs with an altered shape for the detection of programmed cell death - eryptosis. The obtained results can be used to improve the detection of dead RBCs during the routine storage of RBC suspension. The study was approved by the Independent Ethics Committee and the Scientific Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation.

30 June 2025 in Pediatric Hematology/Oncology and Immunopathology
Verified
Journal Article
Open access
PDF file
ICIvan A. Chabin
Ivan A. Chabin
NPNadezhda Podoplelova
Nadezhda Podoplelova
EKEkaterina Koltsova
Ekaterina Koltsova
KBKirill R Butov
Kirill R Butov
SOSergei Ivanovich Obydennyi
Sergei Ivanovich Obydennyi
ОИОбыденный Сергей Иванович
Обыденный Сергей Иванович
There are various mechanisms of red blood cell (RBC) clearance from the circulation, including eryptosis and hemolysis. The spleen plays a major role in eliminating RBCs from the blood flow thanks to their ability to pass through narrow spaces. Still, some questions such as the role of phosphatidylserine-binding proteins in this process remain unanswered. Thus, RBC elimination mechanisms are still not very well explored. Here, we report on a flow cytometry protocol using phosphatidylserine markers for the detection of whole blood erythrocytes that can be classified as pre-elimination RBCs. We also provide the results of healthy donors' blood testing suggesting that reliable detection of eryptosis in whole blood is indeed possible. The study was approved by the Independent Ethics Committee and the Scientific Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of Russia.

Verified
Journal Article
Open access
PDF file
ESElena Sinauridze
Elena Sinauridze
EBElizaveta A. Bovt
Elizaveta A. Bovt
DPDmitry Prudinnik
Dmitry Prudinnik
IDIvan A. Dolgikh
Ivan A. Dolgikh
LKLarisa Koleva
Larisa Koleva
Fazoil I. AtaullakhanovFazoil I. Ataullakhanov
Fazoil I. Ataullakhanov
Hereditary hemolytic anemias (HHAs) have very similar clinical manifestations, complicating differential diagnosis and determining treatment strategies, such as splenectomy. To differentiate between hereditary spherocytosis (HS), pyruvate kinase deficiency (PKD), and hereditary stomatocytosis (HSt), we proposed measuring erythrocyte filterability using membrane filters with a pore diameter of 3 or 3.5 μm. Our modified method provides improved reproducibility, reducing the scattering in results caused by differences in the filters used. Erythrocytes’ filterability differs significantly between patients with HS, HSt, and PKD (medians and 95% confidence intervals were 0.025 [0.004; 0.100] (n = 86); 0.645 [0.520; 0.730] (n = 10), and 0.760 [0.700; 0.782] (n = 26), respectively). The specificity of the filterability test for the HS diagnosis was 99.1%, comparable with the best available tests, while its sensitivity (85.4%) was slightly lower than that of some alternative methods. Only the filterability test was able to identify a second subgroup of HS patients (14.0%) with higher filterability (close to normal), but the diagnosis of HS in these patients could be confirmed by reduced filterability on a 3-μm filter. This subgroup requires further detailed study. The proposed method for measuring filterability is promising for diagnosing HS. It has high sensitivity and specificity and can be performed quickly without expensive equipment.

5 August 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
ESElena Sinauridze
Elena Sinauridze
EBElizaveta A. Bovt
Elizaveta A. Bovt
DPDmitry Prudinnik
Dmitry Prudinnik
IDIvan A. Dolgikh
Ivan A. Dolgikh
LKLarisa Koleva
Larisa Koleva
Fazoil I. AtaullakhanovFazoil I. Ataullakhanov
Fazoil I. Ataullakhanov
Hereditary hemolytic anemias (HHAs) have quite similar clinical manifestations, complicating differential diagnosis and determining treatment, such as splenectomy. For the differential diagnosis of hereditary spherocytosis (HS), pyruvate kinase deficiency (PKD), and hereditary stomatocytosis (HSt), we proposed to measure erythrocyte filterability through membrane filters with a pore diameter of 3 or 3.5 μm. Our modified method provides improved reproducibility reducing the variation in results caused by differences in the filters used. The filterability of erythrocytes significantly differs in patients with HS, HSt and PKD (medians and 1.5 IQR were: 0.045 [0; 0.51] (n=88); 0.685 [0.46; 0.79] (n=12) and 0.75 [0.55; 0.86] (n=28) rel. un., respectively). The specificity of the filterability test for HS diagnosis was 100%, comparable to the best available tests, while its sensitivity (85.2%) was somewhat lower than that of some alternative methods. Only the filterability test could identify a second subgroup in HS patients (14.8%) with higher filterability (close to normal), but their HS diagnosis was confirmed by the decreased filterability by 3-µm pore filter. This subgroup requires further detailed study. The proposed filterability measurement method is promising for diagnosing HS. It has high sensitivity and specificity and can be performed quickly without expensive equipment.